Leveraging automation and data analytics can help facilitate innovation and financial stability.
Part II reviews some lessons learned as we try to predict the trajectory and defenses to COVID-19 test cases.
Monitoring patients through distributed technology will be key to restoring its health.
Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.
During product development, collaboration between software, hardware and quality teams must be tracked and seamless to meet the increasing pace of market demand.
Across our industry, IoMT will enable us to conduct research in ways that would never previously have been possible.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
Operating with an antiquated QMS raises your risk. Here’s what to consider when modernizing your system.
The medical device industry is pressured to aid those stricken by the pandemic, while at the same time working to mitigate increased risks usually associated with hurried manufacturing and quality control procedures.
Investments in new processes and systems must satisfy the needs of the authorities and ensure patient safety and public confidence. Getting it right is likely to be expensive. but regulatory compliance shouldn’t be viewed purely as a cost center.